L-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid, 98.0%, 500g

H-Tyr(tBu)-OH, 98%, 100g

(R)-Benzyl 5-oxotetrahydrofuran-3-ylcarbamate, 97.0%, 5g

9-Fluorenylmethyl Pentafluorophenyl Carbonate>98.0%(HPLC)5g

L-Cystine dihydrochloride, 98.0%, 100g

2-Methylbutyl Acetate>98.0%(GC)25mL

ARCA Cap Analog, ≥98%, 10 µl, emballage plastique.

3-(2-Methyl-2H-pyrazol-3-yl)-propionic acid, 95.0%, 1g

5-Chloro-2-thiophenecarboxaldehyde, 97.0%, 5g

5-Bromo-2-chloro-1H-pyrrolo[2,3-b]pyridine, 97%, 1g

2,2-Difluoro-2-(4-methylphenyl)acetic acid, 95.0%, 250mg

3-(2-(2-(2-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1,3-DIOXOISOINDOLIN-4-YL)AMINO)ETHOXY)ETHOXY)ETHOXY)PROPANOIC ACID, 95%, 100mg

6-Methoxy-3,4-dihydronaphthalen-1(2H)-one, 99.00%, 25g